reports
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offe...
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares NEW HAVEN, Conn., April 20, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced the closing of its previously announced underwritt...
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offe...
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced the pricing of its previously announced underwritten public offering of 11,600,000 shares of its common stoc...
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
Trevi Therapeutics Announces Proposed Public Offering of Common Stock NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. All of the shares in the off...
Trevi Therapeutics to Participate in Upcoming Events
Trevi Therapeutics to Participate in Upcoming Events NEW HAVEN, Conn., April 01, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will be participating in the following events. 25th Annual Needham Virtual Healthcare ConferenceApril 13 – 16, 2026, Virtual Fireside Chat: April ...
- Jonathan Moreland
HTGC HERCULES CAPITAL INC.
FMNB FARMERS NATIONAL BANC CORP.
GAM GENERAL AMERICAN INVESTORS CO. INC.
WVE WAVE LIFE SCIENCES
TSI TCW STRATEGIC INCOME FUND INC.
STIM STIMSONITE CORP
GO GROCERY OUTLET HOLDING
AHCO ADAPTHEALTH
GTLB GITLAB INC
TSM TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
MXF THE MEXICO FUND
GF INC.
AFCG THE NEW GERMANY FUND
VERO INC.
AFC GAMMA
INC.
VENUS CONCEPT INC
Alpine Income Property Trust Announces First Quarter 2026 Earnings Rel...
Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information WINTER PARK, Fla., March 26, 2026 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2026 after the market closes on Thursday, April 23, 2026. A conference call to discuss its financial and operating results is scheduled for Friday, April 24, 2026 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s w...
- Jonathan Moreland
LULU LULULEMON ATHLETICA INC
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
STIM STIMSONITE CORP
REEMF RARE ELEMENT RESOURCES
AHCO ADAPTHEALTH
AIRS AIRSCULPT TECHNOLOGIES INC
MNR MACH NATURAL RESOURCES LP
MXF THE MEXICO FUND
IBIO INC.
GF IBIO INC.
FMBM THE NEW GERMANY FUND
INC.
F & M BANK CORP
- Jonathan Moreland
WAT WATERS CORPORATION
VNO VORNADO REALTY TRUST
TGL. TECNOGLASS INC.
SCM STELLUS CAPITAL INVESTMENT CORP
ROCK GIBRALTAR INDUSTRIES INC.
POOL POOL CORPORATION
OSUR ORASURE TECHNOLOGIES INC.
NSP INSPERITY INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NFBK NORTHFIELD BANCORP INC.
MTN VAIL RESORTS INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
CRM SALESFORCE.COM INC.
BBSI BARRETT BUSINESS SERVICES INC.
WD WALKER & DUNLOP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
BWFG BANKWELL FINANCIAL GROUP
SVRA SAVARA
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
ULBI ULTRALIFE
SONO SONOS
EML THE EASTERN COMPANY
STIM STIMSONITE CORP
BLDR BUILDERS FIRSTSOURCE
AEYE INC.
PHR AUDIOEYE INC
AHCO PHREESIA
AVO ADAPTHEALTH
AMR MISSION PRODUCE
TRIN ALPHA METALLURGICAL RESOURCES INC
AIRS TRINITY CAPITAL INC
EXFY AIRSCULPT TECHNOLOGIES INC
SBSW EXPENSIFY INC
VANI SIBANYE-STILLWATER LTD
GRNT VIVANI MEDICAL INC
NBBK GRANITE RIDGE RESOURCES INC
SDHC NB BANCORP INC.
MXF SMITH DOUGLAS HOMES CORP
SNES THE MEXICO FUND
GF INC.
AFCG SENESTECH INC.
SI THE NEW GERMANY FUND
SENS INC.
AFC GAMMA
INC.
SHOULDER INNOVATIONS INC
SENSEONICS HOLDINGS INC.
- Jonathan Moreland
ALDX ALDEYRA THERAPEUTICS
BBSI BARRETT BUSINESS SERVICES INC.
WD WALKER & DUNLOP INC.
PLBC PLUMAS BANCORP
SVRA SAVARA
EML THE EASTERN COMPANY
STIM STIMSONITE CORP
AMR ALPHA METALLURGICAL RESOURCES INC
ZIP ZIPRECRUITER
AIRS INC.
JOBY AIRSCULPT TECHNOLOGIES INC
INDI JOBY AVIATION INC
NBBK INDIE SEMICONDUCTOR INC
MXF NB BANCORP INC.
GF THE MEXICO FUND
EKSO INC.
THE NEW GERMANY FUND
INC.
EKSO BIONICS HOLDINGS INC.
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial ...
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track to initiate a Phase 2b clinical trial for the treatment of patients with refractory chronic cough in the second quarter of 2026 Company ended 2025 with $188.3 million in cash, cash equivalents and marketable securities, with expected cash runway into 2028 Management to host a co...
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financia...
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026 Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will host a conf...
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with...
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of 2026, with the second pivotal trial expected to initiate in the second half of 2026 NEW HAVEN, Conn., March 09, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the...
Alpine Income Property Trust Announces $32.0 Million First Mortgage Lo...
Alpine Income Property Trust Announces $32.0 Million First Mortgage Loan Investment WINTER PARK, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) today announced the origination of a $32.0 million first mortgage loan investment (the “Loan”), of which $8.6 million was funded at close. The Loan carries a 24-month term with an interest rate of 13.00%, inclusive of 1.5% paid-in-kind interest, stepping down to 11.50% current pay upon the borrower’s satisfaction of certain conditions. The Loan will fund the development of an 11-acre, 101,...
Trevi Therapeutics to Participate in Upcoming March Conferences
Trevi Therapeutics to Participate in Upcoming March Conferences NEW HAVEN, Conn., March 02, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will be participating in the following conferences in March. Leerink Partners 2026 Global Healthcare ConferenceMarch 8 – 11, 2026, Miam...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TTMI TTM TECHNOLOGIES INC.
PFG PRINCIPAL FINANCIAL GROUP INC.
LGIH LGI HOMES INC.
GTE GRAN TIERRA ENERGY
GOOD GLADSTONE COMMERCIAL CORPORATION
GLW CORNING INC
FAN FABRINET
FIX COMFORT SYSTEMS USA INC.
CUBE CUBESMART
CIEN CIENA CORPORATION
AXTI AXT INC.
AAOI APPLIED OPTOELECTRONICS INC.
COHU COHU INC.
OXM OXFORD INDUSTRIES INC.
RELL RICHARDSON ELECTRONICS LTD.
AEHR AEHR TEST SYSTEMS
UAA UNDER ARMOUR INC. CLASS A
TNDM TANDEM DIABETES CARE
FNKO FUNKO CLASS A
ST SENSATA TECHNOLOGIES HOLDING PLC
VICR VICOR CORP.
ATOM ATOMERA
MMMB MAMAMANCINI'S HOLDINGS INC
STNE STONECO
MRNA MODERNA INC.
ATEX ANTERIX INC
XP XP
PRDO PERDOCEO EDUCATION CORP
JAKK JAKKS PACIFIC INC.
SHLS SHOALS TECHNOLOGIES GROUP
COHR COHERENT CORP
SYRE SPYRE THERAPEUTICS INC.
LGCY LEGACY EDUCATION INC.
HOII REX HOOD GROWTH & INCOME ETF
MDLN MEDLINE INC
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
ACN ACCENTURE PLC CLASS A
WK WORKIVA
WDAY WORKDAY INC. CLASS A
THRM GENTHERM INCORPORATED
SXT SENSIENT TECHNOLOGIES CORPORATION
SFM SPROUTS FARMERS MARKETS INC.
NSP INSPERITY INC.
HTGC HERCULES CAPITAL INC.
GPC GENUINE PARTS COMPANY
FELE FRANKLIN ELECTRIC CO. INC.
EXTR EXTREME NETWORKS INC.
EXPE EXPEDIA GROUP INC.
CTSH COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION CLASS A
CRY CRYOLIFE INC.
CPRT COPART INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
ATRC ATRICURE INC.
STN. STANTEC INC
TLX TALANX AG
FLTR FLUTTER ENTERTAINMENT PLC
BRO BROWN & BROWN INC.
SLM SLM CORP
TREE LENDINGTREE INC.
USLM U.S. LIME & MINERALS
WCN WASTE CONNECTIONS INC.
GIB.A CGI INC. CLASS A
CHWY CHEWY INC. CLASS A
QS QUANTUMSCAPE
SOFI SOFI TECHNOLOGIES INC
BWMN BOWMAN CONSULTING GROUP LTD
TPG TPG INC
SMR NUSCALE POWER CORP
ALAB ASTERA LABS INC
CAI CARIS LIFE SCIENCES INC
PTRN PATTERN GROUP INC.
LCID LUCID GROUP INC.
GDYN GRID DYNAMICS HOLDINGS INC.
APPE1 ASAN PARDAKHT PERSIAN ORD
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healt...
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference Fireside chat with management on February 25, 2026, at 9:20 a.m. ET NEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that Jennifer Good, President and Chief Executive Off...
- Michael Piccolo
Daily Recap: CYBR/PANW, EWCZ, CCO, PLBY, UNF/CTAS, YEXT, SSP/SBGI, HZO...
European Wax Center, Inc. (EWCZ - $4.00)Announces $330 Million Take-Private All-Cash Acquisition; Offer Value $5.80/share; Expected Close Mid-2026. EWCZ announced on February 10, 2026, that it has entered into a definitive agreement to be taken private by General Atlantic, a leading global investor
Alpine Income Property Trust Reports Fourth Quarter and Full Year 2025...
Alpine Income Property Trust Reports Fourth Quarter and Full Year 2025 Operating Financial Results – Record $278 Million of Annual Investment Activity in 2025 –– Increases Quarterly Common Stock Dividend by 5.3% –– Announces 2026 Outlook – WINTER PARK, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial income properties, today announced its operating results and earnings for the three months and year ended December 31, 2025. Fourth Quarter and Full Year 2025 Highl...
Alpine Income Property Trust Closes $450 Million Unsecured Credit Agre...
Alpine Income Property Trust Closes $450 Million Unsecured Credit Agreement WINTER PARK, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”), today announced that it closed an amended and restated unsecured credit facility (the “Credit Facility”) with the proceeds used to effectively retire all the Company’s prior unsecured debt. Highlights of the new Credit Facility are as follows: A $450 million unsecured Credit Facility comprised of: a $250 million revolving credit facility due February 2030 with two six-month extension options...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.